Company intelligence / Profile preview

KAME

Surrey, British Columbia, Canada

Ownership: Private
Development stage: Other

Overview

KAM Biotechnology is a specialized biotechnology company focused on the development and application of microbial and enzymatic solutions for environmental and industrial challenges. The company provides a range of products and services designed for bioremediation, waste management, and the treatment of contaminated soil and water. Their expertise lies in identifying and cultivating specific bacterial strains and enzymes that can degrade complex organic pollutants, offering sustainable alternatives to traditional chemical treatments. KAM Biotechnology serves various sectors, including oil and gas, manufacturing, and municipal services, helping clients meet environmental regulations and improve operational efficiency.

Therapeutic areas: Other
Modalities: BiologicSmall molecule
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on KAME.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on KAME.

Explore the full profile